Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million - Reuters

Reuters | April 27, 2026, 10:27 a.m. | Original
Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million Reuters
Israeli strikes hit east Lebanon, expanding scope despite ceasefire - Reuters Bill Ackman's Pershing Square IPO expected to raise $5 billion, Bloomberg News reports - Reuters